Publication: Human selenium binding protein-1 (hSP56) is a negative regulator of HIF-1α and suppresses the malignant characteristics of prostate cancer cells
Open/View Files
Date
2014
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Korean Society for Biochemistry and Molecular Biology
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Jeong, Jee-Yeong, Jin-Rong Zhou, Chong Gao, Laurie Feldman, and Arthur J. Sytkowski. 2014. “Human selenium binding protein-1 (hSP56) is a negative regulator of HIF-1α and suppresses the malignant characteristics of prostate cancer cells.” BMB Reports 47 (7): 411-416. doi:10.5483/BMBRep.2014.47.7.104. http://dx.doi.org/10.5483/BMBRep.2014.47.7.104.
Research Data
Abstract
In the present study, we demonstrate that ectopic expression of 56-kDa human selenium binding protein-1 (hSP56) in PC-3 cells that do not normally express hSP56 results in a marked inhibition of cell growth in vitro and in vivo. Down-regulation of hSP56 in LNCaP cells that normally express hSP56 results in enhanced anchorage-independent growth. PC-3 cells expressing hSP56 exhibit a significant reduction of hypoxia inducible protein (HIF)-1α protein levels under hypoxic conditions without altering HIF-1α mRNA (HIF1A) levels. Taken together, our findings strongly suggest that hSP56 plays a critical role in prostate cells by mechanisms including negative regulation of HIF-1α, thus identifying hSP56 as a candidate anti-oncogene product. [BMB Reports 2014; 47(7): 411-416]
Description
Other Available Sources
Keywords
Hypoxia inducible factor, Prostate cancer, Protein-protein interaction, pVHL-interacting deubiquitinating enzyme, Selenium binding protein
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service